Comparison of the Relative Oral Bioavailability of GKT137831 Formulated in Capsules or in Tablets and Evaluation of the Potential Impact of Concomitant Food Intake on the Relative Bioavailability of GKT137831 in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 18 Feb 2019
Price : $35 *
At a glance
- Drugs Setanaxib (Primary)
- Indications Bile duct diseases; Diabetic nephropathies
- Focus Pharmacokinetics
- Sponsors GenKyoTex
- 11 Feb 2019 Status changed from recruiting to completed.
- 29 Jan 2019 Status changed from not yet recruiting to recruiting.
- 21 Nov 2018 New trial record